Please Wait
Applying Filters...
menu
    • menu
    Polfa Tarchomin is a leading Polish pharmaceutical company with 200 year tradition in manufacture and sale of pharmaceutical products.

    Virtual Booth

    Contact Supplier

    Transo-Pharm GmbH works globally to supply Active Pharmaceutical Ingredients adhering to the highest quality & GMP standards.

    Virtual Booth

    Contact Supplier

    xyz-pharma-m-2025-03-24

    Virtual Booth

    Contact Supplier

    LGM Pharma accelerates & optimizes the new product pathway from early development through commercialization.

    Virtual Booth

    Contact Supplier

    Gentec Pharmaceutical Group is focused on manufacturing & developing APIs/HPAPIs, Advanced Intermediates & Fine Chemicals.

    Virtual Booth

    Contact Supplier

    xyz-pharma-m-2025-03-17

    Virtual Booth

    Contact Supplier

    Menu

    Benznidazole

    ACTIVE PHARMA INGREDIENTS

    DEVELOPMENTS

    FINISHED DOSAGE FORMULATIONS

    RELATED EXCIPIENT COMPANIES

    EXCIPIENTS BY APPLICATIONS

    DIGITAL CONTENT

    PharmaCompass
    Xls

    Filters

    clear-filterReset all filters
    Left Arrow
    Right Arrow

    Digital Content read-more

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    U.S. FDA approves chemo group's benznidazole to treat children Chagas disease
    U.S. FDA approves chemo group's benznidazole to treat children Chagas disease

    31 Aug 2017

    // BIOSPECTRUM

    https://www.biospectrumasia.com/news/33/9403/u-s-fda-approves-chemo-groups-benznidazole-to-treat-children-with-chagas-disease.html

    BIOSPECTRUM
    31 Aug 2017
    Share Share
    U.S. FDA Approves Chemo Group's Benznidazole Treat Children with Chagas Disease
    U.S. FDA Approves Chemo Group's Benznidazole Treat Children with Chagas Disease

    31 Aug 2017

    // PR NEWSWIRE

    http://www.prnewswire.com/news-releases/us-fda-approves-chemo-groups-benznidazole-to-treat-children-with-chagas-disease-642355963.html

    PR NEWSWIRE
    31 Aug 2017
    Share Share
    Nonprofit's Chagas approval thwarts Humanigen bid for rival med
    Nonprofit's Chagas approval thwarts Humanigen bid for rival med

    30 Aug 2017

    // Eric Sagonowsky FIERCE PHARMA

    http://www.fiercepharma.com/regulatory/fda-approval-partnership-takes-a-big-leap-expanding-chagas-drug-access

    Eric Sagonowsky FIERCE PHARMA
    30 Aug 2017
    Share Share
    Rare Diseases Patients Need More Than Miracles And Trumpcare
    Rare Diseases Patients Need More Than Miracles And Trumpcare

    18 Mar 2017

    // Judy Stone FORBES

    https://www.forbes.com/sites/judystone/2017/03/11/rare-disease-patients-need-more-than-miracles-and-trumpcare/

    Judy Stone FORBES
    18 Mar 2017
    Share Share
    Former Shkreli-led drug developer pledges responsible pricing
    Former Shkreli-led drug developer pledges responsible pricing

    12 Apr 2016

    // Natalie Grover REUTERS

    http://www.reuters.com/article/us-kalobios-pricing-idUSKCN0X81HO

    Natalie Grover REUTERS
    12 Apr 2016
    Share Share
    Why Shkreli's Price Hike May Hurt Everyone,Including You & The Pharma Industry
    Why Shkreli's Price Hike May Hurt Everyone,Including You & The Pharma Industry

    16 Dec 2015

    // Bruce Y. Lee FORBES

    http://www.forbes.com/sites/brucelee/2015/12/16/why-martin-shkrelis-price-hike-may-hurt-everyone-including-you-and-the-pharmaceutical-industry/?ss=pharma-healthcare

    Bruce Y. Lee FORBES
    16 Dec 2015
    Share Share